SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-051271
Filing Date
2019-09-25
Accepted
2019-09-25 06:40:57
Documents
5
Period of Report
2019-09-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-18739_38k.htm 8-K 37268
2 EX-4.1 a19-18739_3ex4d1.htm EX-4.1 119263
3 EX-5.1 a19-18739_3ex5d1.htm EX-5.1 6855
4 EX-10.1 a19-18739_3ex10d1.htm EX-10.1 203606
5 GRAPHIC g187393kmi001.gif GRAPHIC 3336
  Complete submission text file 0001104659-19-051271.txt   373056
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 191111999
SIC: 2834 Pharmaceutical Preparations